Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research
Master One Thing - Rapamycin Longevity Series
00:00
Future Plans in Science-Based Longevity and Preventative Medicine
Exploring the speaker's transition from academia to a startup focused on science-based longevity and preventative medicine, advocating for a shift towards proactive healthcare to combat the growing burden of chronic diseases.
Transcript
Play full episode
